The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.

The huge driver of this revenue generated was thanks to the company's obesity drug Zepbound, marketed as Mounjaro for the treatment of patients with Type 2 Diabetes (T2D). There were two key ...

Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head… By: Alexandra Murphy Monday, May 12th, 2025 ...

Novo Nordisk has been ceding market share to Eli Lilly, even though Zepbound's dollar sales still trail Wegovy's. Zepbound and Eli Lilly's diabetes drug Mounjaro now make up over half of U.S ...

Drugs such as Zepbound and Mounjaro helped increase Lilly’s sales nearly 60% from the end of 2022 through last year. During that period, the company’s stock doubled and boosted the coffers of ...

Both navigational bronchoscopy and computed tomography–guided transthoracic needle biopsy are commonly used in patients undergoing biopsies of peripheral pulmonary nodules, but the relative ...

Novo has gone head-to-head with the Indianapolis company for customers, signing contracts with insurers and launching a direct-to-consumer offering to match Lilly's obesity drug Zepbound.

CAPE GIRARDEAU, Mo. (KFVS) - By now most people know someone who has tried the popular weight loss medications. The FDA and a federal court recently made it clear that compounding pharmacies have ...

Below are the most important global events likely to affect FX and bond markets in the week starting May 19. As markets calm after the U.S. and China agreed to slash tariffs for a period of 90 ...

FRANKFURT, Germany — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...